Pfizer Stock Buy Hold or Sell Recommendation

PFE -  USA Stock  

USD 45.68  1.72  3.91%

Considering the 90-day investment horizon and your highly speculative risk level, our recommendation regarding Pfizer Inc is 'Strong Buy'. Macroaxis provides Pfizer buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Pfizer positions. The advice algorithm takes into account all of Pfizer's available fundamental, technical, and predictive indicators you will find on this site.

Search Advice 

 
Refresh
The advice is provided from Pfizer's buy-and-hold perspective. Please check Pfizer Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Pfizer and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Pfizer Inc.

Execute Pfizer Buy or Sell Advice

The Pfizer recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Pfizer Inc. Macroaxis does not own or have any residual interests in Pfizer Inc or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Pfizer's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell PfizerBuy Pfizer
Strong Buy

Volatility

Very steadyDetails

Hype Condition

Low keyDetails

Current Valuation

Fairly ValuedDetails

Odds of Distress

LowDetails

Economic Sensitivity

Slowly supersedes the marketDetails

Analyst Consensus

HoldDetails

Financial Strenth (F Score)

HealthyDetails

Financial Leverage

Very StrongDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Pfizer Inc has a Risk Adjusted Performance of 0.1695, Jensen Alpha of 0.2297, Total Risk Alpha of 0.176, Sortino Ratio of 0.2237 and Treynor Ratio of 0.5812
Pfizer advice module can be used to check and cross-verify current recommendation provided by analysts analyzing the firm's potential to grow using all of fundamental, technical, data market data available at the time. To make sure Pfizer is not overpriced, please check all Pfizer Inc fundamentals, including its cash and equivalents, earnings per share, and the relationship between the revenue and current ratio . Given that Pfizer Inc has a price to earning of 21.69 X, we recommend you to check out Pfizer Inc market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your recent risk tolerance and investing horizon.

Pfizer Trading Alerts and Improvement Suggestions

Pfizer current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Pfizer analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Pfizer analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Mean Price42.97
Target Median Price42.70
Target High Price53.00
Recommendation Mean2.60
Number Of Analyst Opinions20
Target Low Price36.00
Average Consensus Hold
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Pfizer Returns Distribution Density

The distribution of Pfizer's historical returns is an attempt to chart the future uncertainty of Pfizer's future price movements. The chart of the probability distribution of Pfizer stock daily returns describes the distribution of returns around its average expected value. We use Pfizer Inc price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Pfizer returns is essential to provide solid investment advice for Pfizer stock.
Mean Return0.26Value At Risk-1.41
Potential Upside2.69Standard Deviation1.15
 Return Density 
      Distribution 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Pfizer historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Pfizer Cash Flow Accounts

201620172018201920202021 (projected)
Capital Expenditure(2 B)(2.22 B)(2.2 B)(2.59 B)(2.33 B)(2.52 B)
Depreciation Amortization and Accretion5.76 B6.27 B6.38 B6.01 B5.41 B5.58 B
Net Cash Flow or Change in Cash and Cash Equivalents(1.04 B)(1.24 B)(205 M)125 M112.5 M121.38 M
Net Cash Flow Business Acquisitions and Disposals(16.47 B)(18.37 B)(1,000 M)(10.86 B)(12.49 B)(13.48 B)
Issuance Purchase of Equity Shares(3.98 B)(4.14 B)(10.94 B)(8.47 B)(7.62 B)(8.23 B)
Issuance Repayment of Debt Securities2.61 B(941 M)(935 M)8.76 B7.89 B8.51 B
Payment of Dividends and Other Cash Distributions(7.32 B)(7.66 B)(7.98 B)(8.04 B)(7.24 B)(7.81 B)
Net Cash Flow from Financing(8.92 B)(13.04 B)(20.44 B)(8.48 B)(9.65 B)(10.41 B)
Net Cash Flow from Investing(7.81 B)(4.74 B)4.53 B(3.94 B)(4.27 B)(4.61 B)
Net Cash Flow Investment Acquisitions and Disposals12.5 B(2.19 B)6.43 B9.3 B10.7 B11.54 B
Net Cash Flow from Operations15.9 B16.47 B15.83 B12.59 B14.4 B16.69 B
Effect of Exchange Rate Changes on Cash(215 M)53 M(116 M)(32 M)(28.8 M)(31.07 M)
Share Based Compensation691 M840 M949 M718 M825.7 M783.53 M

Pfizer Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Pfizer or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Pfizer stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Pfizer stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over DOW
0.23
β
Beta against DOW0.43
σ
Overall volatility
1.12
Ir
Information ratio 0.18

Pfizer Volatility Alert

Pfizer Inc has low volatility with Treynor Ratio of 0.58, Maximum Drawdown of 5.0 and kurtosis of 1.45. However, we advice all investors to further analyze Pfizer Inc to make certain all market information is desiminated and is consistent with the current expectations about Pfizer upside potential. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Pfizer's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Pfizer's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Pfizer Fundamentals Vs Peers

Comparing Pfizer's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Pfizer's direct or indirect competition across all of the common fundamentals between Pfizer and the related equities. This way, we can detect undervalued stocks with similar characteristics as Pfizer or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Pfizer's fundamental indicators could also be used in its relative valuation, which is a method of valuing Pfizer by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Pfizer to competition
FundamentalsPfizerPeer Average
Return On Equity14.03 %(0.31) %
Return On Asset4.60 %(0.14) %
Profit Margin24.00 %(1.27) %
Operating Margin36.24 %(5.51) %
Current Valuation245.56 B16.62 B
Shares Outstanding5.6 B571.82 M
Shares Owned by Insiders0.04 %10.09 %
Shares Owned by Institutions66.60 %39.21 %
Number of Shares Shorted59.77 M4.71 M
Price to Earning21.69 X28.72 X
Price to Book3.49 X9.51 X
Price to Sales5.16 X11.42 X
Revenue46.41 B9.43 B
Gross Profit33.33 B27.38 B
EBITDA16.82 B3.9 B
Net Income9.38 B570.98 M
Cash and Equivalents13.67 B2.7 B
Cash per Share2.44 X5.01 X
Total Debt39.7 B5.32 B
Debt to Equity0.58 %48.70 %
Current Ratio1.48 X2.16 X
Book Value Per Share12.27 X1.93 K
Cash Flow from Operations15.81 B971.22 M
Short Ratio2.62 X4.00 X
Earnings Per Share1.97 X3.12 X
Price to Earnings To Growth0.82 X4.89 X
Number of Employees78.5 K18.84 K
Beta0.67-0.15
Market Capitalization239.64 B19.03 B
Total Asset167.38 B29.47 B
Retained Earnings90.45 B9.33 B
Working Capital14.4 B1.48 B
Current Asset43.8 B9.34 B
   Acquisition by Jennifer Damico of 1 shares of Pfizer subject to Rule 16b-3 [view details]

About Pfizer Buy or Sell Advice

When is the right time to buy or sell Pfizer Inc? Buying financial instruments such as Pfizer Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Pfizer investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2018 2019 2020 2021 (projected)
Receivables8.03 B8.72 B7.93 B9.85 B
Inventories7.51 B8.28 B8.05 B7.33 B

Use Investing Ideas to Build Portfolios

In addition to having Pfizer in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Realty Thematic Idea Now

Realty
Realty Theme
Funds or Etfs investing in real estate backed instruments or issues backed by different types of commercial properties. Realty theme has 40 constituents.
View All  Next Launch Realty
Please check Pfizer Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Complementary Tools for Pfizer Stock analysis

When running Pfizer Inc price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer Inc underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine Pfizer value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.